Implementing a Pharmacist-Integrated Collaborative Model of Medication Treatment for Opioid Use Disorder
A legfontosabb adatok
- Ki végzi
- Trustees of Dartmouth College
- Hol
- Albuquerque, Nashua, Salt Lake City és Tacoma (Egyesült Államok)Mind a 4 helyszín megnézése
- Azonosító
- Állapot
- Befejeződött
- Résztvevők
- 149 fő vett részt
- Kezdés
- 2022. aug. 18.
- Befejezés
- 2025. febr. 5.
- A vizsgálat típusa
- Beavatkozással járó, 2 csoport
- A vizsgált kezelések
- Pharmacist-integrated Medication Treatment for Opioid Use Disorder (PrIMO)
- A regiszteradat frissítve
- 2025. február 25.
Ki vehet részt
- Életkor
- 18 év felett
- Nem
- Nők és férfiak
- Egészséges önkéntesek
- Nem vehetnek részt
A regiszter feltételei, szó szerint
Mind a 12 feltétel megnézéseKevesebb
Ki vehet részt
- Site Staff
- 18 years of age and older
- Employed at the clinic as an identified stakeholder role (provider, pharmacist, pharmacy technician, or administrator); Patients
- 18 years of age or older
- A patient of the participating clinic who is receiving or has received MOUD from a provider employed by the clinic
- Exposed to the PrIMO model at the clinic site for at least 14 days
Ki nem vehet részt
- Site Staff
- Unwilling or unable to provide consent
- Are currently in jail, prison, or other overnight facility as required by court of law; or have pending legal action that could prevent participation in study activities; Patients
- Not able to speak English sufficiently to understand study procedures and provide written informed consent
- Unable or unwilling to provide consent or to participate in study procedures
- Are currently in jail, prison, or other overnight facility as required by court of law; or have pending legal action that could prevent participation in study activities
Helyszínek itt: Egyesült Államok
- UNM Truman Health ServicesAlbuquerque, Egyesült Államok
- Harbor Health CareNashua, Egyesült Államok
- Sugar House Health CenterSalt Lake City, Egyesült Államok
- Community Health CareTacoma, Egyesült Államok
A vizsgálatról
Mit akar kideríteni a vizsgálat
This project will provide novel empirical information about how to optimally engage pharmacists and pharmacies as key partners in collaborative integrated care models designed to expand access to evidence-based medication treatment for OUD which may inform a larger experimental design that seeks to evaluate best ways to scale-up this model across the nation. This Phase 1 project seeks to evaluate the feasibility, acceptability, and impact of implementing a pharmacist-integrated model of MOUD into approximately four diverse outpatient clinical sites.
A vizsgálat 2 csoportja
- Site StaffEgyéb csoport
Providers, Pharmacists, Pharmacy Technicians, Administrators to receive survey assessments
Kezelés: Pharmacist-integrated Medication Treatment for Opioid Use Disorder (PrIMO)
- PatientsEgyéb csoport
Subset of patients receiving PrIMO care to receive survey assessments
Kezelés: Pharmacist-integrated Medication Treatment for Opioid Use Disorder (PrIMO)
Adatok és források
- Regiszteradat
- Szerepel a ClinicalTrials.gov-on.
- Publikációk
- Feasibility of Implementing a Pharmacist-Integrated Collaborative Model for Opioid Use Disorder: A Nonrandomized Clinical Trial.Journal of general internal medicine, 2026
- Implementing a pharmacist-integrated collaborative model of medication treatment for opioid use disorder in primary care: study design and methodological considerations.Addiction science & clinical practice, 2024
- A regiszteradat frissítve
- 2025. február 25.